Over the past year, major nations have reversed the epidemic, forcing countries to step back and reconsider their immunization measures. Basically, now it’s a competition: Finding more people to shoot helps to spread the word and make new changes. But in Africa, where only a few countries have received so far more vaccines, this process is expected to take a long time. And as the virus continues to spread and spread among people, it continues to change — and translate around the world.
“It’s going to be painful,” says Christian Happi, ACEGIP’s director. “On this continent, we’ve found a number of great species, and there are probably many more.” It is not uncommon for African countries to work together to fight epidemics, he said. Not every country can have a layer machine that integrates genomes quickly, and those that do so often rely on a single commercial lab. As a result, governments and laboratories have learned to work together, and to create networks that use over-the-counter facilities such as Oliveira’s to deal with emerging diseases, rather than exporting samples. So far in 2021, the project has helped double the number of viral genes being tracked in Africa compared to 2020, with the aim of producing 50,000 genomes by the end of the year.
While the potential for successive success begins, the process remains complex, Happi says. The high cost of asymptomatic cases Lack of medical care means that Covid-19 tests that lead to genome classification are rare in some areas. And it is not easy to collect and store samples from all over the region like Somalia and ship them to Nigeria, via several aircraft and supervisors, and store them safely. Of the hundreds of examples on the recent arrival from Mogadishu, the lab produced only 10 shares.
One way to think about the SARS-CoV-2 strains is like the many epidemics within the epidemic. When colors first release, or when they first arrive at a new place, they become like a campfire, ready to catch fire if the opportunity arises to spread and if their change makes them compete with other races. But heat is easier to put out than fires. Various species can be suspended along the border, and tropical eruptions can be detected and destroyed — except for hunter-gatherers go fast and cast a great net. “We need a constant and urgent change, because these species dominate quickly,” said Oliveira. “You do not want to know that it is six months late that you have a certain condition that survives as a result of the vaccine.”
The type of border survey being conducted in Angola, in response to surges linked to other nearby species, is a good example of monitoring, says Oliveira. Examples from the airport are not only the latest challenges, but many examples of B.1.351 and B.1.1.7, complex strains that were first identified in South Africa and the United Kingdom and are circulating around the world. He thinks early detection of this type of crime is crucial because Angola did not face the same fate as its neighbors earlier this year. Travel management also enhances all activities; the researchers had no way to find out in Tanzania, for example, until the three travelers crossed the border.
Despite some difficult challenges, the ability to follow them has a bearing on what government agencies can do. “Planning really helps because you understand the different types of migration,” says Happi. In Nigeria, for example, during the winter, the government expressed concern for surgery unknown. At first it was impossible to know if the virus was spreading rapidly, or if human actions were the cause. Genome compliance revealed that it was run by B.1.1.7, a type that was first identified in the United Kingdom, allowing healthcare workers to identify hot spots and, importantly, giving people an idea of why it was appropriate to hide in the ground. Similarly, when researchers at the Uganda Virus Research Institute he discovered a new species In the vicinity, surveillance resulted in extensive testing in prisons and on passenger lanes, where access was widely available.